Honeywell International Inc. · HON · FY2024 Q3 · Calendar Q4 2024
Honeywell: EPS Resilience Despite Lower Sales Outlook
Honeywell’s latest analysis supports a mixed view: resilient EPS, margins, backlog, and aerospace demand provide evidence of operating strength, but the revenue miss, lower organic-growth outlook, short-cycle weakness, and working-capital pressure temper confidence in near-term growth.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about HON FY2024 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the tone shifted from raised guidance and broad confidence to a lower full-year organic-sales outlook, even as margin expectations improved. The current analysis also emphasizes record backlog, four completed acquisitions, the Advanced Materials spin-off, and AI partnerships as the next execution tests.
Guidance delta
Management lowered full-year organic sales-growth guidance to 3%-4% while raising segment-margin guidance to the high end; the supplied analysis characterizes overall guidance sentiment as lowered.
Key takeaways
- Revenue missed guidance, but adjusted EPS and segment margins reached the high end of guidance.
- Record backlog and strong Energy & Sustainability and Building Automation orders support demand visibility.
- Management lowered full-year organic sales-growth guidance to 3%-4% as short-cycle weakness and disruptions weighed on sales.
- Portfolio reshaping, AI-enabled Forge applications, and installed-base monetization remain central to the 2025 plan.
Management priorities
- Deliver organic growth and margin expansion across the four businesses in 2025.
- Launch AI-enabled Honeywell Forge applications and expand digital monetization.
- Continue portfolio simplification, high-return capital projects, and selected bolt-on acquisitions.
- Use backlog, installed-base services, and new product innovation to support growth.
Follow HON with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 19, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Outperform | Outperform | Maintain | Oct 15, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 14, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 12, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 9, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 31, 2026 |
| B of A Securities | Neutral | Underperform | Upgrade | Jul 28, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 27, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 13, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Jun 30, 2026 |
| Daiwa Capital | Outperform | Neutral | Upgrade | Jun 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jun 10, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jun 3, 2026 |
| TD Cowen | Buy | Buy | Maintain | Apr 24, 2026 |
| Jefferies | Hold | Hold | Maintain | Mar 4, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Feb 27, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jan 30, 2026 |
| Baird | Neutral | Neutral | Maintain | Feb 7, 2025 |
| UBS | Neutral | Sell | Upgrade | Jun 10, 2024 |
| Berenberg | Buy | Hold | Upgrade | Mar 6, 2024 |
| HSBC | Hold | Hold | Maintain | Feb 14, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 3, 2023 |
| Argus Research | Buy | Buy | Maintain | Feb 1, 2021 |
| Bank of America | Buy | Buy | Maintain | Nov 26, 2019 |
| Oppenheimer | Market Perform | Outperform | Downgrade | Jan 8, 2019 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | Apr 23, 2018 |
| Stifel | Buy | Buy | Maintain | Apr 23, 2018 |
| Bernstein | Outperform | Outperform | Maintain | Jul 25, 2016 |
| Ladenburg Thalmann | Buy | Hold | Upgrade | Jan 27, 2014 |
| Nomura | Neutral | Buy | Downgrade | Jul 22, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $211.41. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Analyst unavailable | $255 | $207.61 | +20.6% | Oct 15, 2026 |
| Wells Fargo | Stephen Tusa | $231 | $211.79 | +9.3% | Sep 24, 2026 |
| Morgan Stanley | Analyst unavailable | $250 | $217.43 | +18.3% | Aug 31, 2026 |
| RBC Capital | Analyst unavailable | $293 | $229.15 | +38.6% | Aug 18, 2026 |
| Jefferies | Analyst unavailable | $255 | $229.95 | +20.6% | Aug 17, 2026 |
| Jefferies | Sheila Kahyaoglu | $175 | $246.21 | -17.2% | Aug 9, 2026 |
| Jefferies | Analyst unavailable | $265 | $245.75 | +25.3% | Jul 28, 2026 |
| UBS | Analyst unavailable | $265 | $245.81 | +25.3% | Jul 27, 2026 |
| BMO Capital | Daniel DiCicco | $276 | $243.15 | +30.6% | Jul 27, 2026 |
| RBC Capital | Analyst unavailable | $298 | $242.65 | +41.0% | Jul 24, 2026 |
| Bernstein | Analyst unavailable | $243 | $226.42 | +14.9% | Jul 12, 2026 |
| Wolfe Research | Analyst unavailable | $265 | $220.6 | +25.3% | Jul 9, 2026 |
| Deutsche Bank | Nicole Deblase | $263 | $223.75 | +24.4% | Jun 30, 2026 |
| Daiwa | Analyst unavailable | $255 | $227.8 | +20.6% | Jun 30, 2026 |
| Barclays | Analyst unavailable | $239 | $215.7 | +13.1% | Jun 10, 2026 |
| Bernstein | Varun Govindaraj | $233 | $215.7 | +10.2% | Jun 9, 2026 |
| RBC Capital | Deane Dray | $275 | $217.12 | +30.1% | Jun 5, 2026 |
| Goldman Sachs | Joe Ritchie | $276 | $235.23 | +30.6% | Jun 3, 2026 |
| Wolfe Research | Nigel Coe | $275 | $233 | +30.1% | May 29, 2026 |
| Barclays | Analyst unavailable | $251 | $231.72 | +18.7% | May 27, 2026 |
| Barclays | Analyst unavailable | $243 | $214.34 | +14.9% | Apr 24, 2026 |
| BMO Capital | Analyst unavailable | $273 | $225.17 | +29.1% | Mar 26, 2026 |
| Barclays | Julian Mitchell | $275 | $246.16 | +30.1% | Mar 3, 2026 |
| Goldman Sachs | Analyst unavailable | $262 | $243.97 | +23.9% | Feb 23, 2026 |
| Jefferies | Analyst unavailable | $240 | $229.35 | +13.5% | Feb 3, 2026 |
| RBC Capital | Analyst unavailable | $268 | $228.92 | +26.8% | Jan 30, 2026 |
| Robert W. Baird | Peter Arment | $240 | $227.24 | +13.5% | Jan 30, 2026 |
| Wells Fargo | Joseph O'Dea | $235 | $227.24 | +11.2% | Jan 30, 2026 |
| Barclays | Analyst unavailable | $259 | $227.24 | +22.5% | Jan 30, 2026 |
| Bernstein | Analyst unavailable | $255 | $215.02 | +20.6% | Jan 16, 2026 |
| RBC Capital | Analyst unavailable | $249 | $213.98 | +17.8% | Jan 15, 2026 |
| Wells Fargo | Joseph O'Dea | $215 | $204.94 | +1.7% | Jan 7, 2026 |
| Vertical Research | Jeffrey Sprague | $220 | $199.7 | +4.1% | Jan 5, 2026 |
| Mizuho Securities | Brett Linzey | $240 | $195.88 | +13.5% | Jan 5, 2026 |
| Barclays | Julian Mitchell | $250 | $195.5 | +18.3% | Dec 24, 2025 |
| Evercore ISI | Alexander Virgo | $255 | $193.64 | +20.6% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $269 | $193.47 | +27.2% | Dec 4, 2025 |
| BNP Paribas | Andrew Buscaglia | $195 | $193.15 | -7.8% | Dec 3, 2025 |
| Morgan Stanley | Analyst unavailable | $235 | $213.95 | +11.2% | Oct 28, 2025 |
| Goldman Sachs | Joe Ritchie | $245 | $218.43 | +15.9% | Oct 27, 2025 |
| Wells Fargo | Joseph O'Dea | $230 | $216.14 | +8.8% | Oct 27, 2025 |
| RBC Capital | Deane Dray | $253 | $216.14 | +19.7% | Oct 27, 2025 |
| RBC Capital | Analyst unavailable | $235 | $215.8 | +11.2% | Oct 24, 2025 |
| UBS | Analyst unavailable | $258 | $218.46 | +22.0% | Oct 24, 2025 |
| Barclays | Julian Mitchell | $247 | $213.12 | +16.8% | Mar 26, 2025 |
| Barclays | Julian Mitchell | $255 | $220.63 | +20.6% | Jan 8, 2025 |
| Wells Fargo | Joseph O'Dea | $240 | $220.63 | +13.5% | Jan 7, 2025 |
| Bank of America Securities | Andrew Obin | $230 | $209.1 | +8.8% | Oct 24, 2024 |
| Mizuho Securities | Brett Linzey | $245 | $204.67 | +15.9% | Sep 13, 2024 |
| Morgan Stanley | Chris Snyder | $210 | $202.98 | -0.7% | Sep 6, 2024 |
| RBC Capital | Deane Dray | $214 | $202.28 | +1.2% | Jul 26, 2024 |
| UBS | Damian Karas | $215 | $208.78 | +1.7% | Jun 10, 2024 |
| RBC Capital | Deane Dray | $218 | $205.6 | +3.1% | Jun 4, 2024 |
| Deutsche Bank | Nicole DeBlase | $215 | $194.04 | +1.7% | Apr 15, 2024 |
| Berenberg Bank | Philip Buller | $240 | $200.5 | +13.5% | Mar 6, 2024 |
| J.P. Morgan | Stephen Tusa | $215 | $208.26 | +1.7% | Jul 27, 2023 |
| Wells Fargo | Joseph O’Dea | $180 | $172.8 | -14.9% | Jul 17, 2022 |
| Barclays | Julian Mitchell | $204 | $169.51 | -3.5% | Jul 15, 2022 |
| Deutsche Bank | Nicole DeBlase | $211 | $169.39 | -0.2% | Jul 14, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $194 | $195.19 | -8.2% | Jun 7, 2022 |
| Wells Fargo | Joseph O’Dea | $203 | $195.43 | -4.0% | May 8, 2022 |
| Credit Suisse | Analyst unavailable | $206 | $200.34 | -2.6% | May 2, 2022 |
| Morgan Stanley | Analyst unavailable | $216 | $200.12 | +2.2% | May 2, 2022 |
| Citigroup | Analyst unavailable | $232 | $193.51 | +9.7% | May 2, 2022 |
| Deutsche Bank | Nicole DeBlase | $230 | $192.07 | +8.8% | Apr 19, 2022 |
| Cowen & Co. | Gautam Khanna | $230 | $196.03 | +8.8% | Apr 3, 2022 |
| Wells Fargo | Joseph O’Dea | $209 | $187.43 | -1.1% | Mar 5, 2022 |
| UBS | Markus Mittermaier | $220 | $182.13 | +4.1% | Feb 20, 2022 |
| Wells Fargo | Joseph O'Dea | $205 | $192.48 | -3.0% | Feb 7, 2022 |
| Citigroup | Andrew Kaplowitz | $248 | $191.5 | +17.3% | Feb 6, 2022 |
| J.P. Morgan | Stephen Tusa | $235 | $190.45 | +11.2% | Feb 4, 2022 |
| Robert W. Baird | Peter Arment | $243 | $190.69 | +14.9% | Feb 3, 2022 |
| Mizuho Securities | Brett Linzey | $235 | $190.69 | +11.2% | Feb 3, 2022 |
| Jefferies | Sheila Kahyaoglu | $230 | $203.33 | +8.8% | Jan 23, 2022 |
| Berenberg Bank | Phil Buller | $230 | $216.46 | +8.8% | Jan 14, 2022 |
| Credit Suisse | John Walsh | $226 | $209 | +6.9% | Jan 4, 2022 |
| Bank of America Securities | Andrew Obin | $245 | $203.53 | +15.9% | Dec 8, 2021 |
| Wolfe Research | Nigel Coe | $259 | $221.94 | +22.5% | Jul 12, 2021 |
Track every rating change on HON the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationHoneywell International Inc. functions as a global leader in diversified technology and manufacturing. Its Aerospace division furnishes a comprehensive array of products and services for the aviation and space industries. This includes crucial components like auxiliary power units, propulsion systems, integrated avionics, environmental control mechanisms, and electrical power solutions. The segment also supplies engine controls, flight safety systems, communication and navigation hardware, and advanced data and software applications. Additionally, it provides radar, surveillance systems, aircraft lighting, sophisticated instruments, satellite and space components, and aircraft wheels and brakes. Essential support services cover spare parts, repairs, overhauls, maintenance, thermal systems, and wireless connectivity management. The Honeywell Building Technologies unit focuses on creating smarter, safer, and more efficient structures.…
Historical context
All HON earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| JBHT J.B. Hunt Transport Services, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.6% | -2.0% | J.B. Hunt: Strong demand, but margin repair remains central |
| FAST Fastenal Company | FY2026 Q3 · Calendar Q4 2026 | +3.3% | +1.1% | Fastenal Q3: Share Gains and Digital Adoption Lift Growth |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the HON recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-19T08:00:44.900423+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-19T08:00:44.897182+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-19. For educational purposes only; not investment advice.